HomeTagsDrug

drug

Tianjin Pharmaceutical Da Ren Tang Is Shrinking To Succeed In FY2025

How TJ DRT’s 33% Revenue "Loss" Fueled a 72% Margin Miracle and a Record...

Why China Medical Systems FY2025 Profits Dropped Despite Growth

https://open.spotify.com/episode/3YAldvdzS4eXE4RzkN9M18?si=8a54594510534cfe 5 Game-Changing Takeaways from CMS’s 2025 Transformation For the Chinese pharmaceutical sector, 2025 was the...

iX Biopharma’s Secret Shortcut To The US Medical Market – 1H FY2026

From Cash Burn to Bioavailability: How iX Biopharma Slashed Losses by 67% via a...

iX Biopharma’s Robust FY2025 Performance and Strategic Outlook

iX Biopharma LTD achieved robust financial performance with significant revenue and gross profit growth,...
spot_img

Latest articles

Abundante Limited Doubles HY2026 Net Profit As Fleet Investments Pay Off

Surging Profits Driven By Fleet Modernization and Sharp Execution Abundante Limited delivered a strong performance...

Duty Free International 1H FY2027 Revenue Rises Amid Legacy Trading Loss

Revenue Surge Meets Net Loss During the first half of FY2027 (6M FY2027), Duty Free...

Deluge Corporation Launches Mainboard IPO On SGX

Why This IPO Deserves a Closer Look When investors think of high-growth sectors, fire sprinklers...

Top Glove Achieves Major Operational & Financial Turnaround In FY2026

Turnaround Story Top Glove Corporation Bhd has staged a major operational and financial recovery in...